Status:
COMPLETED
Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
Lead Sponsor:
Centers for Disease Control and Prevention
Conditions:
HIV Infections
Hepatitis C
Eligibility:
All Genders
15-30 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that c...
Detailed Description
CIDUS III/DUIT is a five-city (Baltimore, Chicago, Los Angeles, New York, and Seattle) randomized controlled trial to develop and evaluate the efficacy of a six-session behavioral intervention for HIV...
Eligibility Criteria
Inclusion
- age 15-30 years old
- self-reported illicit drug injection within the past 6 months
- live in the geographic region under study and plan to stay for \>12 months
- willing to provide a blood sample for serologic testing
- willing to provide basic contact information for follow-up
- able to communicate in English
- had not participated in the pilot study or previously enrolled in the trial
- not concurrently participating in other HIV or HCV intervention trials
- tested HIV and HCV seronegative at baseline
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT00164372
Start Date
May 1 2002
End Date
December 1 2006
Last Update
September 27 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Research Association
Los Angeles, California, United States, 90010
2
University of Illinois at Chicago
Chicago, Illinois, United States, 60612
3
Johns Hopkins University
Baltimore, Maryland, United States, 21205
4
New York Academy of Medicine
New York, New York, United States, 10029